Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-Ap, NSC #663249) for Locally Advanced Cervical Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2469
Full Text
Open PDFAbstract
Available in full text
Date
February 9, 2010
Authors
Publisher
American Association for Cancer Research (AACR)